P-275 FOLFOX versus FOLFIRI as second-line treatment after cisplatin-gemcitabine in patients with advanced biliary tract cancers

Autor: Nichetti, F., Rizzato, M., Bensi, M., Salani, F., Franza, A., Piva, V., Cerantola, R., Chiaravalli, M., Masi, G., Djaballah, S. Ahcene, Barone, D., Vivaldi, C., Bergamo, F., Rota, S., Di Bartolomeo, M., de Braud, F., Niger, M., Lonardi, S.
Zdroj: In Annals of Oncology June 2023 34 Supplement 1:S113-S113
Databáze: ScienceDirect